Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a period of time at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at treatment of liver. He published more than 647 peer-reviewed research papers, and registered 14 UK and International patents. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awardsâ€™ Winner of Most Innovative New Product 2012 for the â€œsynthetic tracheaâ€. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. He has over 15,000 media report from his achievement, include BBC, ITV, WSJ, CNN, and many more. Currently he is working on development and commercialisation of human organs using graphene based nanocomposite materials and stem cells technology.
Mr. De la Parra is an entrepreneur focused on Information Technology, Education and Health. He is creative and results-driven and has 16+ years of Digital Strategy experience in architecture and implementation.
Mr. De la Parra is the COO and Co-founding Partner at The Solomon Brokerage Firm. He currently leads as CEO at Mass Media Division & De la Parra Mobile Solutions, while also being the President of PetroM Renewable, VP of Operations & Strategy at PetroM Logistics, both divisions of PetroM Corp. Former COO & Co-founder at RegenerAgeÂ® Clinic & RegenerAgeÂ® Beauty & a member of the Board of Advisors. Former CEO & Founder at Astrum Salud MÃ³vil and its Telemedicine service Astrum MÃ³vil, former Digital Strategy Director & Co-founder at Dr. JoisÂ®, BiorganicAgingÂ®, What Skin Needsâ„¢/WSN International Pty. Ltd. He also served as a member of the Board of Advisors and is former CMO at ReAnima Advanced Biosciences and former Digital Media Director at Bioquark, Inc.
Within the academic and educational fields, Mr. De la Parra acted as the Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, a member of the WAMS Executive Council (WAMS Executive Board), a member of the WAMS Education & Training Board (ETB), a member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & is also a Senior Partner at WAMS, The World Academy of Medical Sciences. He is also an Advisory Board member, functioned as the Chief Operating Officer and is a Co-founding Partner at The Reprogramming Medicine Association.
Mr. De la Parra is also a member of the National Introducing Brokers Association and a part of the National Biofuel Board, (Alliance Program), also being the founder and former Board of Directors member of Astrum FundaciÃ³n, an Advisory Board member of the Lifeboat Foundation, an Advisory Board member of the Future Worlds Center - Cyprus Neuroscience & Technology Institute (Senior TV Program), a Federated member of the International Longevity Alliance, and volunteered as Digital Strategy adviser at the Major Mouse Testing Program. He is also a member of the Web Committee at the Life Extension Advocacy Foundation / Lifespan.io and has volunteered with SENS Research Foundation for the OncoSENS Program in Digital Strategy.
Alejandro De la Parra Solomon(Research Area)
Neuroscience, Regenerative Medicine, Continued Medical Education, Information & Communications Technology, Biotechnology, Social Development, Energy Technologies
Dr Martins completed his undergraduate Science degree at the University of Western Australia in 1984, then completing a MSc in Clinical Biochemistry in 1986. In 1987 he commenced a Ph D studying the role of high density lipoprotein (HDL) in diabetes (Hackett Scholarship). In 1993 he was awarded a Saw fellowship from the University of Western Australia to conduct studies relating to the metabolism of chylomicrons and their remnants and the influence of size and composition on their clearance from blood and its importance to atherosclerosis.
The publications between 1988-2000 have shown that Dr Martins has made a valuable and solid contribution to the field of atherosclerosis and heart disease. His work has concentrated on understanding the role of dietary cholesterol rich particles and the subsequent clearance and metabolism from the blood plasma and their potential risk for the development of heart disease. These research studies have shown that the type of dietary fat and increased consumption are important risk factors for heart disease.
Zeliha Selamoglu is a Professor in Medical Biology department of Nigde Ã–mer Halisdemir
University, Turkey. She earned her PhD in Biology from Inonu University, She has published
over 110 peerreviewed journal articles with over 1160 citations and many technical reports.
She is a member of Society for Experimental Biology and Medicine: Associate Membership
and European association for cancer research. She has served as Editorial Board member for
Zeliha Selamoglu(Research Area)
Medical Biology, Molecular Biology, Biochemistry, Oxidative Stress, Antioxidants, Cancer.
Professor MD, FWAMS, Ilie Vasiliev. Academy Professor of Medicine, The First Vice-President of the World Academy of Medical Sciences, The Chairman of the General Council of the World Academy of Medical Sciences (World Medical Council), The Chairman of the WAMS National Council of Moldova, The Fellow of the Academy,The Member of the WAMS Executive Council, The Member of the WAMS International Scientific Council, The Member of the WAMS Education and Training Board, Senior Executive Board Member of the World Academy of Medical Sciences, Senior Fellow of the World Academy of Medical Sciences, Senior Member of the â€œAcademy Facultyâ€, Executive Senior Board Member of the WAMS' International Medical Research Council! Chief Executive Officer Research Port. Session Chair International Conference on Biotechnology, Biomarkers & Systems Biology, March, 2019. Amsterdam, with the presentation of the keynote information and the Global Summit on Medicine, Pharmacology & Cancer Research wit WAMS Barcelona, Spain 2018.
Ilie Vasiliev(Research Area)
Cardiology, Medicine and Pharmacy "Nicolae Testemitanu".